Tsumura China to acquire stake in Hongqiao drug pieces

Tsumura & Co. [TSE:4540] announced that its Chinese group company, Tsumura China Inc., will acquire 51% of the shares of Shanghai Hongqiao Traditional Chinese Drug Pieces Co., Ltd. ("Hongqiao Drug Pieces"). The decision, formalized at a Board of Directors meeting on June 18, 2025, marks a significant step in Tsumura's long-term management vision, "TSUMURA VISION "Cho-WA" 2031," aimed at contributing to well-being through traditional medicines and personalized healthcare solutions. The acquisition will bolster Tsumura's crude drug platform in China, leveraging Hongqiao Drug Pieces' market presence and Tsumura's expertise in traceability, research, and manufacturing. The deal involves Tsumura China acquiring the shares for CNY 1,162,800,000. Tsumura China has CNY 2,528 million in capital, while Hongqiao Drug Pieces reported net assets of CNY 235,357,000 for the year ended December 2024. The share transfer is expected to be completed in July 2025, pending further analysis of its impact on Tsumura's consolidated financial results for the fiscal year ending March 31, 2026.